オハイオにおける結腸癌の臨床試験
オハイオ内の拠点で、結腸癌に関する23件の研究が参加者を募集しています。
オハイオ内の都市
公式研究テキスト（英語）
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- TriHealth Cancer Institute-Westside, Cincinnati
- 他1件
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07283939Family Communications After Genetic Testing
- Aultman Alliance Community Hospital, Alliance
- Indu and Raj Soin Medical Center, Beavercreek
- Saint Elizabeth Boardman Hospital, Boardman
- 他17件
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07143487A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Miami Valley Hospital South ( Site 0075), Centerville
- University of Cincinnati Medical Center ( Site 2005), Cincinnati
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06997497A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- ALX Center 10, Columbus
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07085091Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Oncology Hematology Care - Eastgate, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
- Oncology Hematology Care Clinical Trials, LLC, Fairfield
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07222800A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
- GSK Investigational Site, Canton
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07213609A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- University of Cincinnati Cancer Institute, Cincinnati
- Case Comprehensive Cancer Center, Cleveland
- Ohio State University-Arthur G James Comprehensive Cancer Center, Columbus
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/15更新 · NCT07284849EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
被験者募集中
18歳以上 · 全性別 · 2026/09/15更新 · NCT06263088ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Cleveland Clinic, Cleveland
- Toledo Clinic Cancer Center, Toledo
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- UHHS-Chagrin Highlands Medical Center, Beachwood
- Miami Valley Hospital South, Centerville
- Good Samaritan Hospital - Cincinnati, Cincinnati
- 他13件
被験者募集中
45歳〜70歳 · 全性別 · 2026/09/02更新 · NCT05080673Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Summa Health System - Akron Campus, Akron
- Cleveland Clinic Akron General, Akron
- Aultman Alliance Community Hospital, Alliance
- 他65件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/02更新 · NCT05174169Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Xencor Investigative Site, Cincinnati
- Xencor Investigative Site, Columbus
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/03更新 · NCT05433142Strategies for Optimizing a Mailed FIT Program in Appalachia
- Ohio State University Comprehensive Cancer Center, Columbus
被験者募集中
45歳〜74歳 · 全性別 · 2026/07/09更新 · NCT07173985Integrated Cancer Repository for Cancer Research
- Aultman Alliance Community Hospital, Alliance
- Aultman Hospital, Canton
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- The Ohio State University Comprehensive Cancer Center, Columbus
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/12更新 · NCT06051695Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- The Christ Hospital, Cincinnati
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/03更新 · NCT06040541A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- The Ohio State University Wexner Medical Center, Columbus
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/05/27更新 · NCT03093116Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Christ Hospital Cancer Center, Cincinnati
- Taylor Cancer Research Center, Maumee
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/15更新 · NCT05379985Designing a Dyad-Based mHealth Intervention to Improve Adherence to Lifestyle Recommendations in Colorectal Cancer Survivors and Their Family Caregivers
- Ohio State University Comprehensive Cancer Center, Columbus
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/04/09更新 · NCT06746012The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors
- University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
被験者募集中観察研究
18歳以上 · 全性別 · 2026/04/09更新 · NCT04624555Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- GSK Investigational Site, Akron
- GSK Investigational Site, Cincinnati
被験者募集中第3相
18歳以上 · 全性別 · 2026/01/23更新 · NCT05855200SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Cincinnati
- Massive Bio SYNERGY-AI site, Columbus
- Massive Bio SYNERGY-AI site, Mayfield Heights
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- The Ohio State University, Columbus
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/09/09更新 · NCT06682793ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。